Navigation Links
TrialNetworks Customer Steve Sweeney of Arteaus Therapeutics Encourages Clinical Trial Sponsors to Treat Investigative Sites Like Customers by Using Innovative Technology
Date:1/10/2014

Needham, MA (PRWEB) January 10, 2014

Platforms like TrialNetworks’ unique Clinical Trial Optimization System can be used by pharmaceutical companies to improve sponsor-site relations, says TrialNetworks client Steven P. Sweeney, Vice President and Head of Clinical Development Operations for Arteaus Therapeutics, in a new article published by the Journal for Clinical Research Best Practices.

The article, “Treat Your Sites Like Customers... and Use Technology to Help Do It,” examines the cost of poor sponsor-site relationships and urges sponsors to change their mindset and fix communication problems. Steve says that sponsors can leverage solutions such as the exclusive TrialNetworks platform to keep sites engaged through consistent communication strategies, online training apps, helpful visit guides, support tools, and more. Topics covered include:

  •     How to assess your current communication practices
  •     An overview of clinical trial portals and communication platforms
  •     Functions that can be improved by such technology
  •     Site adoption case study during a 13-month trial

TrialNetworks Co-Founder and CEO Eric Silberstein said, “Steve Sweeney is a visionary clinical research executive with whom we have had the pleasure of working for several years on multiple trials. We share his passion for site advocacy and his belief that technology platforms like ours help innovative sponsors improve site communications and relationships. We admire and congratulate him for sharing his experiences and advice on how to radically improve clinical trial operations in this important article.”

To discover how the TrialNetworks platform is revolutionizing clinical trial optimization, request a demo at http://www.trialnetworks.com.

About TrialNetworks
TrialNetworks, co-founded by U.S. Surgeon General nominee Dr. Vivek Murthy, provides sponsors and CROs the industry's only Clinical Trial Optimization System. Using this modern and intuitive technology, customers such as Merck & Co., Biogen Idec and Infinity Pharmaceuticals are able to transform the quality and efficiency of clinical operations at each stage of a trial from feasibility through closeout. TrialNetworks apps, including Checklist™, Training™, Document Library™, Visit Guide™, Action Items™ and Directory™, are available in a unified and secure cloud-based interface.

Customers ranging from biotechs to Top-10 pharma companies have implemented the TrialNetworks platform for use in Phase I-IV trials by more than 25,000 site staff in 60 countries. To learn why sponsors and CROs rely on TrialNetworks to optimize clinical trial operations, request a guided online demo at http://www.trialnetworks.com.

Read the full story at http://www.prweb.com/releases/2014/01/prweb11479184.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. TrialNetworks Customer to Present Results of Using Site Engagement Technology to Improve Study Operations and Patient Enrollment at Clinical Trial Optimization Conference
2. TrialNetworks Feasibility Survey™ App Gets ARIAD Pharmaceuticals Unprecedented 75% Response from Potential Clinical Trial Investigator Sites
3. TrialNetworks Sees Strong Growth in Demand for its Clinical Trial Optimization System as Pharma Seeks Technology to Improve Operations Quality and Efficiency
4. TrialNetworks Co-founder and Chairman Vivek Murthy, MD, MBA, Nominated by President Barack Obama as Surgeon General of the United States of America
5. Customer Satisfaction, A key to Success: Narang Medical Limited
6. TAKE Solutions Brings Together Leading Experts and TAKE Customers at “Converge 2012” to Discuss Business
7. Transportation and Energy Customers Look to Wharfedale’s SAP® Solutions with an Eye toward Cost Savings and Improved Operational Efficiencies
8. Sangui Bio Tech International Inc. - Over 500 Customers: Granulox Sales Ahead of Planning
9. Z Trim Holdings Grows Customer Base
10. BioInformatics LLC Announces New Market Report – Enhancing the Customer Experience: Insights and Life Science Supplier Rankings (13-002)
11. SoundConnect Announces New Not-For-Profit Customer in Smart Card Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2017)... ... July 13, 2017 , ... Thousands of pilots from across ... the National Aeromodeling Championships (Nats). Pilots come to Muncie to compete in various categories ... on US teams that participate in world championships. , RC Pylon (July 14-21): One ...
(Date:7/13/2017)... ... 13, 2017 , ... Frederick’s first and only science and ... the past year after an intensive restructuring. Under the leadership of CEO Kathie ... its board of directors to revitalize the organization. As a result, FITCI is ...
(Date:7/12/2017)... ... 12, 2017 , ... Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a ... for diagnostic tests, announced today that its initial public offering of 1,178,532 shares of ... offering will be $7,071,192. , The shares will begin trading on July 12, 2017 ...
(Date:7/12/2017)... ... July 12, 2017 , ... Exact Diagnostics continues to ensure consistent results by ... use. Panels available include: Adenovirus, BKV, CMV, EBV, HBV, HCV, HHV-6A, ... Verification Panels may be used as calibrators to establish reference points for the measurement ...
Breaking Biology Technology:
(Date:4/17/2017)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... 2016 Annual Report on Form 10-K on Thursday April 13, 2017 ... ... Investor Relations section of the Company,s website at http://www.nxt-id.com  under ... http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/11/2017)... , April 11, 2017 Crossmatch®, a ... authentication solutions, today announced that it has been ... Research Projects Activity (IARPA) to develop next-generation Presentation ... "Innovation has been a driving force ... program will allow us to innovate and develop ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
Breaking Biology News(10 mins):